This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2020
Title: Joong Ku Lee: Innovator in Pharmaceutical Compositions
Introduction
Joong Ku Lee is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical compositions, particularly in the treatment of respiratory diseases. With a total of 7 patents, his work focuses on innovative solutions for chronic obstructive pulmonary disease (COPD) and asthma.
Latest Patents
One of his latest patents involves a pharmaceutical composition comprising an extract, fraction, or compound aimed at preventing or treating COPD. This invention highlights a composition that suppresses the invasion of inflammatory cells into the bronchial tubes of a COPD-induced animal model. It effectively reduces the expression of inflammatory markers such as CXCL-1, TNF-α, and MIP-2. The use of a safety-proven herbal drug as a raw material addresses various side effects associated with existing therapeutic agents for COPD and related conditions.
Another notable patent focuses on a composition for preventing or treating asthma, which includes an extract or fraction of J. Poiss. ex Franch. This composition has shown to inhibit the generation of inflammatory mediators and reactive oxygen species in the bronchial tubes. It significantly alleviates airway hyperresponsiveness and reduces inflammatory cell infiltration in an ovalbumin-induced asthma mouse model. The safety and efficacy of this preparation make it a valuable option for asthma treatment.
Career Highlights
Joong Ku Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research and development. His work is characterized by a commitment to creating safe and effective pharmaceutical solutions for respiratory diseases.
Collaborations
He collaborates with notable colleagues, including Kyung Seop Ahn and Sei Ryang Oh, to advance his research and innovations in the field.
Conclusion
Joong Ku Lee's contributions to pharmaceutical compositions for respiratory diseases demonstrate his dedication to improving health outcomes. His innovative patents reflect a deep understanding of the complexities of respiratory conditions and a commitment to developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile